XML 41 R31.htm IDEA: XBRL DOCUMENT

Revenue from contracts with customers (Tables)

9 Months Ended

Sep. 30, 2024

Summary of disaggregates revenues by major revenue streams

The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.


		Three months ended September 30, 2024
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			1,822				1,214				568				121				3,794
Licensing arrangements			23				9				6				8				45
Distribution			380				§				10				—				390
Other			§				42				29				100				102

		$	2,225			$	1,265			$	613			$	229			$	4,332

§	Represents an amount less than $0.5 million.


		Three months ended September 30, 2023
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			1,500				1,117				556				130				3,303
Licensing arrangements			30				13				9				1				53
Distribution			366				§				11				—				377
Other			§				15				15				86				117

		$	1,896			$	1,146			$	591			$	217			$	3,850

§	Represents an amount less than $0.5 million.


		Nine months ended September 30, 2024
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			4,857				3,668				1,708				399				10,701
Licensing arrangements			68				26				17				10				121
Distribution			1,134				§				28				—				1,163
Other			§				54				49				295				330

		$	6,060			$	3,749			$	1,802			$	703			$	12,315

§	Represents an amount less than $0.5 million.


		Nine months ended September 30, 2023
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			4,210				3,446				1,656				412				9,724
Licensing arrangements			72				38				21				4				134
Distribution			1,183				§				29				—				1,212
Other			§				8				44				265				318

		$	5,465			$	3,493			$	1,750			$	681			$	11,389

§	Represents an amount less than $0.5 million.

Summary of Sales Reserves and Allowances


		Sales Reserves and Allowances
		Reserves included in Accounts Receivable, net				Rebates				Medicaid and other governmental allowances				Chargebacks				Returns				Other				Total reserves included in Sales Reserves and Allowances				Total
		(U.S.$ in millions)
Balance at January 1, 2024		$	61			$	1,603			$	540			$	859			$	436			$	97			$	3,535			$	3,596
Provisions related to sales made in current year period			294				3,436				579				5,925				191				146				10,277				10,571
Provisions related to sales made in prior periods			—				16				26				(11	)			(28	)			(2	)			1				1
Credits and payments			(292	)			(3,269	)			(556	)			(5,877	)			(209	)			(121	)			(10,032	)			(10,324	)
Translation differences			—				1				3				1				(1	)			—				4				4

Balance at September 30, 2024		$	63			$	1,787			$	592			$	897			$	389			$	120			$	3,785			$	3,848


		Sales Reserves and Allowances
		Reserves included in Accounts Receivable, net				Rebates				Medicaid and other governmental allowances				Chargebacks				Returns				Other				Total reserves included in Sales Reserves and Allowances				Total

		(U.S.$ in millions)
Balance at January 1, 2023		$	67			$	1,575			$	663			$	991			$	455			$	66			$	3,750			$	3,817
Provisions related to sales made in current year period			262				2,968				468				5,636				205				73				9,350				9,612
Provisions related to sales made in prior periods			—				(22	)			(33	)			(21	)			24				—				(52	)			(52	)
Credits and payments			(268	)			(2,989	)			(617	)			(5,768	)			(251	)			(53	)			(9,678	)			(9,946	)
Translation differences			—				(8	)			(2	)			(3	)			—				(6	)			(19	)			(19	)

Balance at September 30, 2023		$	61			$	1,524			$	479			$	835			$	433			$	80			$	3,351			$	3,412